By InvitationNot Applicable

Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes

United States40 participantsStarted 2021-03-01

Plain-language summary

Increased pain after cleft palate surgery is the leading cause of increased hospital length of stay, delayed oral intake, readmission, and respiratory compromise. The goal is to improve all outcomes by identifying the most effective evidenced-based method of intra-operative pain control.

Who can participate

Age range9 Months – 2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing primary cleft palate repair at Ann \& Robert H. Lurie Children's Hospital of Chicago during the enrollment period. The typical child at the time of cleft palate repair is age 11 to 12 months. Exclusion Criteria: * Children with a known allergy to local anesthesia (i.e., ropivacaine or bupivacaine). * Children with prior surgical repair of the palate.

What they're measuring

Evaluation of ultrasound-guided bilateral suprazygomatic maxillary nerve block on postoperative pain scores.

Timeframe: 48 hours after discharge

Evaluation of ultrasound-guided bilateral suprazygomatic maxillary nerve block on perioperative analgesia requirements.

Timeframe: 48 hours after discharge

Trial details

NCT IDNCT04909619

SponsorAnn & Robert H Lurie Children's Hospital of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Cleft Palate Children trials